[ACE inhibitors or AT1 receptor antagonists?]

Dtsch Med Wochenschr. 1999 Sep 24:124 Suppl 2:S37-9.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Age Factors
  • Aged
  • Angiotensin I / antagonists & inhibitors*
  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / therapeutic use
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / therapeutic use
  • Biphenyl Compounds / administration & dosage
  • Biphenyl Compounds / therapeutic use
  • Captopril / administration & dosage
  • Captopril / therapeutic use
  • Clinical Trials as Topic
  • Death, Sudden, Cardiac / prevention & control
  • Enalapril / administration & dosage
  • Enalapril / therapeutic use
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Losartan / administration & dosage
  • Losartan / therapeutic use
  • Prodrugs
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Tetrazoles / administration & dosage
  • Tetrazoles / therapeutic use
  • Time Factors

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Prodrugs
  • Tetrazoles
  • Enalapril
  • Angiotensin I
  • Captopril
  • Losartan
  • candesartan cilexetil
  • candesartan